Walleye Capital LLC Embecta Corp. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.13 - $14.6 $978,892 - $1.41 Million	96,633 Added 283.78%	130,685 $1.63 Million
Q1 2024 May 15, 2024	BUY	$12.35 - $19.33 $206,096 - $322,579	16,688 Added 96.11%	34,052 $451,000
Q4 2023 Feb 14, 2024	BUY	$12.87 - $19.09 $223,474 - $331,478	17,364 New	17,364 $328,000
Q2 2022 Aug 08, 2022	SELL	$24.78 - $33.36 $251,789 - $338,970	-10,161 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$33.33 - $47.0 $338,666 - $477,567	10,161 New	10,161 $339,000

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.12B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.